177lu-psma-617,olaparib
novartis,astrazeneca,merck
['psma-617 ', 'olaparib', 'luparp', '177lu,psma,617', 'crpc', 'prostate']
#luparp: phase 1 trial of 177lu-psma-617 and olaparib in patients with metastatic castration-resistant #prostatecancer #mcrpc. presentation by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology